Image Source: Pixabay

Orion Oyj is known by the trading ticker symbol, ORINY. It is listed in the Healthcare sector as a General Drug Manufacturer. This is my first report on Orion Oyj for my Vista stock Portfolio. I did recommend the stock in a previous portfolio.

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. 

The company primarily focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. 

Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries and North America.

The company has a collaboration with Nanoform to apply Nanoform's CESS technology to new chemical entities. It serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. 

Orion Oyj has a partnership with Propeller Health to connect the Easyhaler(R) line of inhalers for asthma and COPD to Propeller's digital medicine platform. 

Orion Oyj is headquartered in Espoo, Finland.

Three key data points gauge dividend equities or funds like Orion Oyj:

(1) Price

(2) Dividends

(3) Returns

Those three basic keys best tell whether any company has made, is making, and will make money. 

ORINY Price

Orion Oyj's price per share was $21.30 as of yesterday's market close. One year ago its price was $25.05. So ORINY's share price has fallen almost 15% in the past year. 

If Orion Oyj stock trades in the range of $20 to $24 this next year, its recent $21.30 price might rise by $0.70 to reach $22.00 by August 10, 2022. My estimate is based on the annual average price increase for ORINY for the past 6 years. 

ORINY Dividends

Orion Oyj's most recent regular annual dividend payout of  $0.89 was paid on April 22nd and projected an annual yield of 4.18% based on yesterday's $21.30 closing price. ORINY has paid annual dividends for 6 years.

ORINY Returns

Adding the $0.89 annual ORINY forward-looking dividend to my $0.70 price upside estimate shows a $1.59 potential gross gain, per share, to be reduced by any costs to trade Orion Oyj shares.  

At yesterday's $21.30.70 price per share, a little over $1000 would buy 47 shares.

A $10 broker fee (if charged) would be paid half at purchase and half at a sale and might cost us about $0.21 per share.

Subtract that maybe $0.21 brokerage cost from my estimated $1.59 gross gain per share results in a net gain of $1.38 X 47 shares = $64.86 for a 6.45% net gain on a $1,001.10 investment.

So it is that Orion Oyj shows a possible 6.45% net gain including a 4.18% forward estimated dividend yield. 

Over the next year at this time, a $1000 investment in Orion Oyj could generate $41.80 in cash dividends alone. And a single share bought at yesterday's closing price was $21.30! Thus, ORINY's share price is now about 51% of the dividend income from $1K invested. So, according to my dividend dogcatcher ideal, this is a good time to pick up Orion Oyj shares because the dividend from $1k invested exceeds the single share price by almost 2 times. Consider yourself alerted.    

All of the estimates above are speculation based on the past history of Orion Oyj. Only time and money invested in this stock will determine its market value.